Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

• Biogen’s stock hit by soft sales of Alzheimer’s treatment

  Business - MarketWatch - October 30

• Sony raises guidance on gaming strength, quarterly operating profit beats estimates

  Business - CNBC - November 8

• Bristol Myers’s stock pops as earnings top estimates and company raises guidance

  Business - MarketWatch - October 31

• Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

  Business - CNBC - October 30

• Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

  Business - MarketWatch - 6 days ago

• Pfizer’s earnings crush estimates as company raises guidance

  Business - MarketWatch - October 29

• Far right gains traction in EU assembly

  World - Financial Times - 7 hours ago

More from CNBC

• Nvidia shares slump 3% in premarket as quarterly revenue growth slows

  Business - CNBC - 1 hour ago

• Eli Manning, Derek Jeter, Jimmy Fallon join TGL New York Golf Club investor group

  Business - CNBC - 1 hour ago

• Adani Group slams 'baseless' New York fraud and bribery charges

  Business - CNBC - 2 hours ago

• Williams-Sonoma CEO explains pricing strategy after earnings beat

  Business - CNBC - 12 hours ago

• Bitcoin hits fresh record, races toward $100,000 as rally continues

  Business - CNBC - 38 minutes ago